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NC-ND license (http://creativecommoBackground: Various investigations have demonstrated that calcitonin gene-related peptide
(CGRP) plays an important role in mediating ischemic preconditioning. CGRP has been shown
to mimic the protective effects of ischemic preconditioning and mitigate ischemia-
reperfusion (I/R) injury in the heart, brain, gastrointestinal system, and other tissues. This
study aimed to examine whether CGRP, a proven intestinal cytoprotective molecule, exerted
its protective effects through modulation of inducible nitride oxide synthase (iNOS) and
apoptosis after intestinal I/R injury.
Methods: This animal study randomly divided 30 rats into the following five groups: (1) the
normal control group, (2) the ischemia group with normal saline, (3) the I/R group with normal
saline, (4) the ischemia group with CGRP (300 mg/kg), and (5) the I/R group with CGRP (300 mg/
kg). Levels of iNOS messenger RNA (mRNA) and protein, and caspase-3 protein were deter-
mined by real-time quantitative polymerase chain reaction and Western blotting analyses,
respectively. Statistical analysis was performed using analysis of variance with Dunn test.Gastroenterology, Department of Pediatrics, Chang Gung Children’s Medical Center, Chang Gung
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CGRP downregulates iNOS and caspase-3 after I/R injury 475Results: The mRNA levels of iNOS increased after the intestinal ischemia or intestinal reperfu-
sion phase (p < 0.01), and CGRP pretreatment significantly decreased iNOS mRNAs and protein
levels (p < 0.01). The expression protein levels of caspase-3 increased after the intestinal
ischemia or intestinal reperfusion phase. CGRP pretreatment significantly decreased the levels
of caspase-3 proteins. CGRP intestinal cytoprotection is mediated, in part, by downregulation
of expression of iNOS and caspase-3 after intestinal I/R injury.
Conclusion: The study indicates that the cytoprotective role of CGRP (i.e., antiapoptotic ef-
fect) after I/R injury could be via downregulation of iNOS, which may relieve I/R tissue damage
by blocking iNOS activity.
Copyright ª 2016, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Intestinal ischemia-reperfusion (I/R) injury is known to be a
key factor in the pathogenesis of various clinical conditions,
such as midgut volvulus, neonatal necrotizing enterocolitis,
intestinal transplantation, and hemorrhagic shock with
resuscitation.1 The precise mechanisms of intestinal I/R
injury have not yet been fully elucidated, and there is
currently no specific treatment once ischemia has
occurred. However, more recent reports have noted that
apoptosis is a significant and perhaps principal contributor
to cell death after I/R injury.2,3
The development of intestinal injury following I/R ap-
pears to involve the endogenous production of inflamma-
tory mediators such as platelet-activating factor (PAF),
tumor necrosis factor-a (TNF-a), and other cytokines,2 and
increasing evidence suggests that the vasodilator NO may
be involved in this process.4 There is ample evidence that I/
R injury is associated with inducible nitride oxide synthase
(iNOS) and sustained NO production in several organs
including the heart, brain, muscle, and pancreas.5 Dramatic
upregulation of iNOS is induced by inflammatory cytokines
during intestinal injury, leading to a very rapid and quan-
titatively massive generation of NO, which participates in
the generation of tissue injury.
Calcitonin gene-related peptide (CGRP) is a 37-amino
acid peptide that is generated by tissue-specific alterna-
tive processing pathway of the calcitonin/CGRP gene.6
CGRP exerts multiple biological effects on the central
nervous, cardiovascular, and gastrointestinal systems.7
CGRP plays an important role in mediating communica-
tions between the nervous, endocrine, and immune sys-
tems. CGRP has pleiotropic functions that have been
implicated in the regulation of cell proliferation,8
apoptosis,9 and differentiation.10 Recently, CGRP has
been reported to exert a protective effect against organ
damage in several disease models.11,12 In a previous study,
CGRP exerted a significant antiapoptotic effect on cultured
hepatocytes treated with interferon-a. Furthermore, pre-
treatment with CGRP significantly inhibited TNF-a-induced
apoptosis in cultured endothelial cells.13
This animal study evaluates the role of CGRP, a proven
intestinal cytoprotective molecule, in I/R injury by regu-
lating the expressions of iNOS and caspase-3.2. Methods2.1. Experimental protocol
After obtaining approval from the Chang Gung Memorial
Hospital Animal Research and Ethics Committee, Taoyuan,
Taiwan, adult, Sprague-Dawley rats (weighing 200e300 g;
aged 8e12 weeks) were anesthetized with Chloradurat
(Merk Ltd., Germany) (10%) intraperitoneally. Midline
laparotomy was performed, the small intestine was re-
flected to the left, and a 10-cm segment of the distal
isolated ileal loop was created. The marginal vessels were
divided, resulting in complete separation of the vascular
supply to the loop. The mesentery of the isolated loop was
occluded for 30 minutes in experimental animals with a
micro-bulldog clamp. At the end of the ischemic period,
the clamp was released and the bowel became pink. Ani-
mal preparations and methods of surgery have been
described in detail in a previous paper.14 For treated ani-
mals, a dose of 300 mg/kg of CGRP (Sigma-Aldrich, St Louis,
MO) was given in a total volume of 1.5 mL of saline. The
preparation was injected through the internal jugular
vein. The injection was given 5 minutes before the initia-
tion of ischemia.
Thirty rats were randomly divided into the following five
groups: the normal control group (n Z 6) with sham oper-
ation; the disease group (n Z 12) including the ischemia
group, receiving vascular occlusion for 30 minutes with
normal saline; the I/R group, receiving vascular occlusion
for 30 minutes and reperfusion for 30 minutes with normal
saline; the disease experimental group including the
ischemia group with CGRP (300 mg/kg); and the I/R group
with (300 mg/kg). A total of 30 rats were used in this
experiment.
2.2. Collection of samples
Rats were killed by intramuscular injection of ketamine. A
3-cm occluded ileum was then excised. The isolated ileum
was gently rolled with cotton swabs and flushed with cold
(4C) normal saline to remove the luminal contents, blotted
dry, weighed, frozen in liquid nitrogen, and stored at 80C
for subsequent analysis.
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polymerase chain reaction
Total RNA was isolated using the modified acid phenol
extraction method developed by Nathan and Xie.15 Total
RNA was quantified and qualified by spectrophotometry
(NanoDrop Technologies Inc., Wilmington, DE, USA). RNA
was treated with RQ1 RNase-Free DNase I (Promega, Madi-
son, WI, USA) for 30 minutes at 37C according to the
manufacturer’s instructions. DNase-treated RNA samples
were reverse transcribed with Superscript (Invitrogen,
Carlsband, CA, USA) using oligo dT. Quantitative real-time
polymerase chain reactions (PCRs) were performed using
SYBR GreenSupermix (Bio-Rad, Hercules, CA, USA) in 20 mL
total volume and a Bio-Rad iCycler iQ Real-Time Detection
System according to the manufacturer’s instructions.
Primer sequences are shown as follows: iNOS forward 50-
GCTTGCCCCTGGAACTTT-30 and reverse 50-AAACTCAGGGG-
CAAGC-30; glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) forward 50-TCA CAA GGT GCT GCT TTC-AC-30 and
reverse 50-GCT CGG GTC TCT GAC AAA TC-30. Q-PCR cycle
conditions were 3 minutes at 95C, 15 seconds at 95C, and
45 seconds at 60C for 55 cycles. Performing primer matrix
reactions and generating standard curves for iNOS and
GAPDH determined optimal PCR conditions. PCRs were
performed in triplicate and relative expression level of iNOS
in different groups was calculated by normalizing the dataFigure 1 The inducible nitride oxide synthase (iNOS) messenge
ischemia-reperfusion (I/R) groups compared with the control gro
deviation. Effect of I/R injury and pretreatment of calcitonin gen
levels increased in the ischemia and I/R groups, and it decreased af
induction  standard deviation. * p < 0.01 relative to the compar
treatment, and y p < 0.01 relative to the comparison between the
saline.to alpha-tubulin expression level using the comparative CT
method, where CT represents the cycle numbers at which
the amplification reaches a threshold level chosen to lie in
the exponential phase of all PCRs. Data were analyzed
using the iCycler iQ system software (Bio-Rad).2.4. Western blotting
Frozen rat intestinal tissues were ground using a mortar and
pestle with liquid nitrogen (or homogenized) and lysed in
PRO-PREP Protein Extraction Solution (iNtRON Biotech-
nology) according to the manufacturer’s instructions. Pro-
teins were quantitated by Bradford analysis.
Tissue lysates (total protein 50 mg) were separated by
10% sodium dodecyl sulfateepolyacrylamide gel electro-
phoresis and transferred to polyvinylidene difluoride
membrane (Millipore Corporation, Billerica, MA, USA).
Membranes were blocked with 5% nonfat milk in Tris-
buffered saline and Tween 20 buffer (150mM NaCl, 10mM
Tris/pH 8.0, and 0.05% Tween-20) at room temperature for
1 hour. The membranes were then immunoblotted with
primary antibodies (cFos and cJun 1:1000, b-actin 1:50,000;
Chemicon, Millipore Corporation) overnight at 4C, fol-
lowed by incubation with secondary antibodies for 1 hour at
room temperature (AP124P; Chemicon). Blots visualized by
a chemiluminescence ECL system (Millipore Corporation)r RNA (mRNA) levels markedly increased in the ischemia and
up. Data are expressed as median fold induction  standard
e-related peptide (CGRP) on iNOS expression. The iNOS mRNA
ter pretreatment with CGRP. Data are expressed as median fold
ison between the ischemia groups without and with CGRP pre-
I/R groups without and with CGRP pretreatment. NS Z normal
Figure 2 Western blotting for detection of effects of
ischemia-reperfusion (I/R) injury and pretreatment of calci-
tonin gene-related peptide (CGRP) on the protein level of
inducible nitride oxide synthase (iNOS). The protein level of
iNOS was strongly detected in the ischemia and I/R groups.
CGRP administration decreased iNOS protein levels in the
ischemia and I/R groups. The bar graph shows mean data of
protein densitometries computed as the ratio of protein to
GAPDH. * and y indicate p < 0.01 relative to the comparison
between the ischemia and I/R groups without and with CGRP
pretreatment, respectively. NS Z normal saline.
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Profil BIO-1Dþþ software.
2.5. Statistical analysis
Results are expressed as median  standard deviation. The
results of the mRNA levels of iNOS in different groups were
analyzed by repeated measures of analysis of variance with
post hoc comparison (Dunn test). A p value < 0.05 was
considered statistically significant.
3. Results
The intensity of each band was measured, standardized by
the internal control gene (GAPDH ), and the sequential
patterns of relative expression were shown. The expression
of iNOS increased in the ischemia and I/R groups (p < 0.01),
and it was fivefold higher than that of the control group.
However, it decreased to almost the same level as the
control in the ischemia and I/R groups with CGRP (p < 0.01;
Figure 1).
Western blotting analysis of protein levels was per-
formed to demonstrate that increased iNOS protein level
was strongly detected in the ischemia and I/R groups. In
addition, CGRP pretreatment resulted in significantly
decreased iNOS level compared with the ischemia and I/R
groups (Figure 2).
The expression of caspase-3 protein levels was strongly
detected in the ischemia and I/R groups. CGRP pretreat-
ment revealed that caspase-3 protein levels were signifi-
cantly decreased compared with the ischemia and I/R
groups (Figure 3).
4. Discussion
The pathogenesis of necrotizing enterocolitis is unknown,
but I/R injury has been considered to be a major contrib-
uting factor. Apoptosis is a significant and perhaps principal
contributor to cell death after I/R injury. Recent studies
have revealed that inhibitors of iNOS led to attenuation of
NO production and decrease of hypoxia-induced intestinal
apoptosis. The mechanism of hypoxia-induced intestinal
damage is not clear. It has been reported that ischemia-
induced tissue damage is milder than the damage occurring
after reperfusion. Parks and Granger1 suggested that a
greater part of intestinal mucosal damage was caused by
cytotoxic oxidants formed after reperfusion. Intestinal I/R
injury may promote gut barrier failure and bacterial
translocation, contributing to the development of multiple
organ failure by allowing bacteria or endotoxin that is
normally contained within the gut to reach the systemic
and portal circulations. As in sepsis, necrotizing enteroco-
litis, and other diseases, the development of intestinal
injury following I/R appears to involve the endogenous
production of inflammatory mediators such as PAF, TNF-a,
and other cytokines,2 and evidence is accumulating that
the vasodilator NO may also be involved.4
NO is recognized as an important mediator of physio-
logical and pathological processes.15 NO or endothelium-
derived relaxing factor, produced from the guanidinegroup of L-arginine, has recently been purported to be an
important physiological regulator of intestinal blood flow as
well as of mucosal barrier function.16,17 NO is produced by
NOS, and three main isoforms of NOS have been identified,
namely, neuronal NOS (nNOS), endothelial NOS (eNOS), and
iNOS.15 Although nNOS and eNOS tend to be naturally pre-
sent and are expressed constitutively at low levels, they
produce picomolar amounts of NO. By contrast, iNOS is
usually absent, but, when induced by inflammatory cyto-
kines, it yields macromolar quantities of NO. All three iso-
forms are present throughout the gastrointestinal tract.18
Regarding the relationship between iNOS and apoptosis,
a high concentration of NO produced by iNOS has been
recognized as a cause of apoptosis within a wide range of
cells. NO can induce caspase-mediated apoptosis in a va-
riety of cell types including pancreatic islets and neurons.
Despite the potentially protective effect of NO, there is
ample evidence indicating that high levels of NO induce
apoptosis and mediate tissue damage in different cell types
including epithelial cells during I/R. Inhibitors of iNOS led to
Figure 3 Western blotting for detection of effects of
ischemia-reperfusion (I/R) injury and pretreatment of calci-
tonin gene-related peptide (CGRP) on the protein level of
caspase-3. The protein level of caspase-3 was strongly detec-
ted in the ischemia and I/R groups. CGRP administration
decreased caspase-3 protein levels in the ischemia and I/R
groups. * and y indicate p < 0. 01 relative to the comparison
between the ischemia and I/R groups without and with CGRP
pretreatment, respectively. NS Z normal saline.
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induced intestinal apoptosis.19 In this paper, we have
demonstrated that the expression of iNOS mRNA and cas-
pase protein increases in a rat model after the ischemia and
reperfusion phases. Considering the aforementioned
finding, it seems reasonable to support the fact that iNOS is
closely related to the expression of caspase, and this may
be definite evidence that iNOS directly induces apoptosis.
CGRP, one of the major neurotransmitters of capsaicin-
sensitive sensory nerves, is widely distributed in the ner-
vous and cardiovascular systems.20 Interestingly, it has
been shown that the local source of CGRP may have special
physiological significance. CGRP is a 37-amino acid peptidegenerated by tissue-specific alternative processing of the
calcitonin/CGRP gene.6 CGRP exerts multiple biological
effects on the central nervous, cardiovascular, and
gastrointestinal systems.7 CGRP also plays an important
role in mediating communications between the nervous,
endocrine, and immune systems.
Several recent studies have focused on cellular
apoptosis as an underlying mechanism of warm and/or cold
I/R injury. A relationship between apoptosis and intestinal
I/R injury was reported in previous papers. Previous in-
vestigations demonstrated that CGRP played an important
role in the I/R injuries of the myocardium, brain, gastro-
intestinal system, and other tissues.8,11,21e23 CGRP has
been shown to be involved in apoptosis. Shichiri et al24
demonstrated that both CGRP and adrenomedullin
induced the expression of max, a heterodimeric partner of
c-Myc, which may contribute to the rescue of endothelial
cells from apoptosis. The pretreatment with CGRP induced
better protection of cells resulting in a decrease in the
apoptotic process of rat thymocytes.25 More recently,
several reports have investigated whether CGRP can
attenuate apoptosis in myocardial, hepatic, and retinal I/R
injury.26e28
In summary, the data presented in this report reveal that
pretreatment of CGRP significantly decreased the levels of
iNOS mRNA and caspase-3 protein after intestinal I/R
injury. These results may further support the assertion that
the cytoprotective role of CGRP (i.e., antiapoptotic effect)
after I/R injury could be via downregulation of iNOS. It may
be clinically useful in the future to relieve such tissue
damage by blocking iNOS activity. The question of whether
CGRP can be further applied to the clinical use for ischemic
disease remains an issue for further investigation.
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